Top Markets
Coin of the day
Histogen Inc. Histogen Inc.

Histogen Inc.

HSTO
주식 순위 #40868
Histogen Inc. operates as a clinical-stage biotechnology company, focusing on... Histogen Inc. operates as a clinical-stage biotechnology company, focusing on the development of novel, stem cell-free biologic products derived from its proprietary hypoxia-generated growth factor technology platform. Among its offerings is HST-003, a human extracellular matrix, currently undergoing Phase 1/2 clinical trials to mend articular cartilage defects in the knee. Additionally, the company is advancing HST-004, a cell-conditioned media solution designed for spinal disc repair, and Emricasan, an orally active pan-caspase inhibitor targeting COVID-19 treatment. In its preclinical pipeline, Histogen is developing CTS-2090 and CTS-2096. These are selective caspase-1 inhibitors formulated to suppress inflammasome activation and intervene in a range of inflammation-mediated conditions. Founded in 2007, Histogen Inc. maintains its headquarters in San Diego, California.
주가
$0.02765
마지막 동기화: 2024-12-23
시가총액
$69.04K
변동 (1일)
0.00%
변동 (1년)
0.00%
국가
US
거래 Histogen Inc. (HSTO)

카테고리

Histogen Inc. (HSTO)의 배당 수익률 기록
Histogen Inc. (주식 심볼: HSTO)의 배당 수익률 (TTM)은 2021-12-31 기준으로 0.00%입니다.
지난 5년 평균 배당 수익률: 0.00%
Histogen Inc. (HSTO)의 배당 수익률 기록: 2011 ~ 2026
연도별 말 기준 배당 수익률 (TTM)
연도 배당 수익률 변화
2026 (TTM) 0.00% 0.00%
2022 0.00% 0.00%
2021 0.00% 0.00%
2020 0.00% 0.00%
2019 0.00% 0.00%
2018 0.00% 0.00%
2017 0.00% 0.00%
2016 0.00% 0.00%
2015 0.00% 0.00%
2014 0.00% 0.00%
2013 0.00% 0.00%
2012 0.00% 0.00%
2011 0.00% 0.00%
유사 기업 또는 경쟁사의 배당 수익률 (TTM)